Sonoma Biotherapeutics Stock

Invents personalized T cell therapies for autoimmune diseases.

Buy

Buy Sonoma Biotherapeutics shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Sonoma Biotherapeutics shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

Sonoma Biotherapeutics is inventing the future of living therapies for autoimmune disease — safe, effective treatments as unique as each individual patient. Regulatory T cell therapies that harness a patient’s own immune cells, powerful next generation gene editing techniques and advanced manufacturing and quality assurance processes. Sonoma’s mission is to create a best-in-class regulatory T cell therapy that delivers long-lasting, highly efficacious treatments leading to cures across a spectrum of autoimmune and degenerative diseases.

Sector

Healthcare & Life Sciences

Founded

2019

Headquarters

South San Francisco, CA

Buy

Buy Sonoma Biotherapeutics shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Sonoma Biotherapeutics shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Sonoma Biotherapeutics Management Team

Sonoma Biotherapeutics people and management

  • Co-Founder, CEO, Board Member, President
    Jeffrey Bluestone
  • Board Member
    Toni Hoover
  • Board Member
    Maggie Wilderotter
  • Board Member
    Terry Rosen
  • Board Member
    John C. Davis
  • Board Member
    Carlos Solórzano
  • Chairman
    Richard Klausner
  • Co-Founder
    Fred Ramsdell
  • Co-Founder
    Qizhi Tang
  • Co-Founder
    Alexander Rudensky
  • Board Member
    Carlos Solórzano

Investors

Major Sonoma Biotherapeutics investors

  • Vertex Ventures

  • Piper Heartland Healthcare Capital

  • Osage University Partners

  • Octagon Investments

  • NS Investment

  • Mirae Asset Capital

  • Milky Way Ventures

  • Lyell Immunopharma

  • Lilly Asia Ventures

  • LifeForce Capital

  • JDRF T1D Fund

  • Google Ventures

  • Frazier Healthcare Ventures

  • Fidelity

  • Deep Track Capital

  • Casdin Capital

  • Avidity Partners

  • ArrowMark Partners

  • ARCH Venture Partners

  • Ally Bridge Group

  • Alexandria Venture Investments

  • 8VC

Sonoma Biotherapeutics Valuations & Financials

Gain Insights Into Sonoma Biotherapeutics Stock Valuation & Share Prices

View real-time NPM data on Sonoma Biotherapeutics stock including daily Sonoma Biotherapeutics stock price estimates, valuation history, and historical share price information. Access Sonoma Biotherapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Sonoma Biotherapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Sonoma Biotherapeutics? Get in touch to learn more.

Similar Companies

Explore companies

like Sonoma Biotherapeutics

  • Virta Health-Logo

    Virta Health

    Healthcare & Life Sciences

    Online specialty medical clinic focused on reversing type 2 diabetes.

  • Elligo Health Research

    Healthcare & Life Sciences

    Connects healthcare sites, sponsors, and patients to streamline clinical trial access through technology and data-driven solutions.

  • Droplet Biosciences

    Healthcare & Life Sciences

    Turning surgical drain fluid into powerful, early molecular insights to guide personalized post-surgery cancer care.

  • Hinge Health-Logo

    Hinge Health

    Healthcare & Life Sciences

    Digital clinic for back, joint, and muscle pain.

  • Cerebral

    Healthcare & Life Sciences

    Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

  • Insitro-Logo

    insitro

    Healthcare & Life Sciences

    Drug discovery and development company.

  • Cedar Inc-Logo

    Cedar

    Healthcare & Life Sciences

    The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.

  • Weareresilience-Logo

    Resilience

    Healthcare & Life Sciences

    Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

  • Eikon Therapeutics Inc-Logo

    Eikon Therapeutics

    Healthcare & Life Sciences

    Uses revolutionary technology to discover novel treatments for life-threatening diseases.

FAQ

Questions?

We have answers

Buy Sonoma Biotherapeutics Stock

Sonoma Biotherapeutics stock does not trade on public stock exchanges. Sonoma Biotherapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Sonoma Biotherapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Sonoma Biotherapeutics Stock

Sonoma Biotherapeutics Stock does not trade on public stock exchanges. In order to sell Sonoma Biotherapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

 

Sonoma Biotherapeutics Stock Price

Sonoma Biotherapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Sonoma Biotherapeutics share price and other valuable private market data.

Read more about secondary market private company stock prices:

Sonoma Biotherapeutics Stock Ticker Symbol

There is no ticker symbol for Sonoma Biotherapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Sonoma Biotherapeutics Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Sonoma Biotherapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Sonoma Biotherapeutics Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Sonoma Biotherapeutics stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Sonoma Biotherapeutics Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Sonoma Biotherapeutics IPO

Sonoma Biotherapeutics is a private company and has not had an IPO. There is currently no Sonoma Biotherapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Sonoma Biotherapeutics IPO.

Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.